Innoviva Inc (INVA)

Innoviva Inc (INVA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.5B; returns 1 day -1.9%, 1 week -0.6%, 1 year +13.1%.

Innoviva Inc (INVA) is a biopharmaceutical company primarily generating revenue through royalty interests in respiratory medicines developed in partnership with GlaxoSmithKline (GSK). Its business model is asset-light, focused on receiving royalties from net sales of key products rather than direct R&D or manufacturing.

Groups INVA belongs to

• Shrinking Share Count
• Biopharmaceutical
• Royalty Streams
• Asset-Light Model
• Chronic Obstructive Pulmonary Disease (COPD)
• Healthcare
• Pharmaceuticals
• Healthcare Services
• Strategic Acquisitions

INVA financial model: income statement, cash flow and balance sheet